- Home
- ECDA vs AGEN Comparison
ECDA vs AGEN Comparison
Compare ECDA & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECDA
- AGEN
- Stock Information
- Founded
- ECDA 2013
- AGEN 1994
- Country
- ECDA United States
- AGEN United States
- Employees
- ECDA N/A
- AGEN N/A
- Industry
- ECDA Auto Manufacturing
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECDA Consumer Discretionary
- AGEN Health Care
- Exchange
- ECDA Nasdaq
- AGEN Nasdaq
- Market Cap
- ECDA 34.8M
- AGEN 38.1M
- IPO Year
- ECDA N/A
- AGEN 2000
- Fundamental
- Price
- ECDA $0.35
- AGEN $2.85
- Analyst Decision
- ECDA
- AGEN Buy
- Analyst Count
- ECDA 0
- AGEN 4
- Target Price
- ECDA N/A
- AGEN $8.00
- AVG Volume (30 Days)
- ECDA 429.7K
- AGEN 712.2K
- Earning Date
- ECDA 04-15-2025
- AGEN 05-06-2025
- Dividend Yield
- ECDA N/A
- AGEN N/A
- EPS Growth
- ECDA N/A
- AGEN N/A
- EPS
- ECDA N/A
- AGEN N/A
- Revenue
- ECDA $25,165,733.00
- AGEN $103,463,000.00
- Revenue This Year
- ECDA $69.94
- AGEN $4.03
- Revenue Next Year
- ECDA N/A
- AGEN $5.57
- P/E Ratio
- ECDA N/A
- AGEN N/A
- Revenue Growth
- ECDA 29.10
- AGEN N/A
- 52 Week Low
- ECDA $0.45
- AGEN $1.38
- 52 Week High
- ECDA $1.45
- AGEN $19.69
- Technical
- Relative Strength Index (RSI)
- ECDA 28.35
- AGEN 72.36
- Support Level
- ECDA $0.30
- AGEN $1.60
- Resistance Level
- ECDA $0.87
- AGEN $1.83
- Average True Range (ATR)
- ECDA 0.15
- AGEN 0.32
- MACD
- ECDA -0.02
- AGEN 0.18
- Stochastic Oscillator
- ECDA 11.02
- AGEN 72.77
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).